(HealthDay News) — Almost 15 percent of U.S. adults aged 50 to 80 years are taking aspirin for primary cardiovascular disease prevention, according to a brief report published in the July 1 issue of ...

Taking ‘baby aspirin' doses daily cuts the heightened risk of bowel cancer in half in those with Lynch Syndrome, a genetic disorder that faces a higher risk of several cancers, according to a new ...

I am a healthy 89-year-old United States Army veteran. In August 2017, I was diagnosed with advanced prostate cancer and was treated with Lupron and radiation.

Drug repurposing is undervalued, but it offers potential benefits for patients and healthcare systems, argue Ruth Langley and colleagues Drug repurposing involves finding new indications for ...

Addressing a longstanding controversy in cancer prevention, a large randomized trial showed that low-dose aspirin reduced the risk of colorectal cancer (CRC) in patients with Lynch syndrome just as ...

A groundbreaking new study reveals that a simple, low-dose aspirin—already found in millions of homes—can slash the risk of colon cancer by 50%. Especially effective for people with Lynch syndrome, ...

New research suggests that low-dose aspirin is as effective as higher doses in preventing colorectal cancer in people with a particular hereditary condition.

An aspirin a day can prevent bowel cancer in people at high risk of the disease, research has confirmed. A new trial of 1,900 participants suggests GPs can recommend a low dose aspirin for people ...

A study to find the right dose of aspirin to reduce the risk of cancer in some patients has found the smallest amount works just as well as larger ones, according to a leading researcher. The ...

ASPIRIN could be prescribed to try to prevent bowel cancer for those in a high-risk group. A Cancer Research UK study found a small daily dose offers protection for people with Lynch syndrome.